These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7691988)

  • 1. Conformation-dependent recognition of baculovirus-expressed Epstein-Barr virus gp350 by a panel of monoclonal antibodies.
    Zhang PF; Marcus-Sekura CJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2171-9. PubMed ID: 7691988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the epitopes of Epstein-Barr virus gp350 using monoclonal antibodies and recombinant proteins expressed in Escherichia coli defines three antigenic determinants.
    Zhang PF; Klutch M; Armstrong G; Qualtiere L; Pearson G; Marcus-Sekura CJ
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2747-55. PubMed ID: 1719128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule.
    Tanner JE; Coinçon M; Leblond V; Hu J; Fang JM; Sygusch J; Alfieri C
    J Virol; 2015 May; 89(9):4932-41. PubMed ID: 25694592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo.
    Servat E; Ro BW; Cayatte C; Gemmell L; Barton C; Rao E; Lin R; Zuo F; Woo JC; Hayes GM
    Vaccine; 2015 Nov; 33(48):6771-7. PubMed ID: 26485517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope mapping of the major Epstein-Barr virus outer envelope glycoprotein gp350/220.
    Qualtiere LF; Decoteau JF; Hassan Nasr-el-Din M
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():535-43. PubMed ID: 2434608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the endogenously expressed Epstein-Barr virus (EBV) envelope glycoprotein gp350 with the viral receptor masks the major EBV-neutralizing epitope and affects gp350-specific ADCC.
    Khyatti M; Ahmad A; Blagdon M; Frade R; Menezes J
    J Leukoc Biol; 1998 Aug; 64(2):192-7. PubMed ID: 9715258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Epstein-Barr virus membrane antigen gp350/220 in E. coli and in insect cells.
    Nuebling CM; Buck M; Boos H; von Deimling A; Mueller-Lantzsch N
    Virology; 1992 Nov; 191(1):443-7. PubMed ID: 1329330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes.
    Mutsvunguma LZ; Rodriguez E; Escalante GM; Muniraju M; Williams JC; Warden C; Qin H; Wang J; Wu X; Barasa A; Mulama DH; Mwangi W; Ogembo JG
    Virology; 2019 Oct; 536():1-15. PubMed ID: 31377598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profile of a human monoclonal antibody Fab fragment specific for Epstein-Barr virus gp350/220 antigen.
    Bugli F; Bastidas R; Burton DR; Williamson RA; Clementi M; Burioni R
    Hum Immunol; 2001 Apr; 62(4):362-7. PubMed ID: 11295468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.
    Herrman M; Mühe J; Quink C; Wang F
    J Virol; 2016 Feb; 90(3):1222-30. PubMed ID: 26559839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Epstein-Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine.
    Jackman WT; Mann KA; Hoffmann HJ; Spaete RR
    Vaccine; 1999 Feb; 17(7-8):660-8. PubMed ID: 10067671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
    Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE
    J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin.
    Ragot T; Finerty S; Watkins PE; Perricaudet M; Morgan AJ
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():501-7. PubMed ID: 8383183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity.
    Khyatti M; Patel PC; Stefanescu I; Menezes J
    J Virol; 1991 Feb; 65(2):996-1001. PubMed ID: 1846213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clones.
    Khyatti M; Patel PC; Menezes J
    Int J Cancer; 1991 Jun; 48(4):591-7. PubMed ID: 1646179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic analysis of the Epstein-Barr virus major membrane antigen (gp350/220) expressed in yeast and mammalian cells: implications for the development of a subunit vaccine.
    Emini EA; Schleif WA; Armstrong ME; Silberklang M; Schultz LD; Lehman D; Maigetter RZ; Qualtiere LF; Pearson GR; Ellis RW
    Virology; 1988 Oct; 166(2):387-93. PubMed ID: 2845652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the Epstein-Barr virus envelope fusion glycoprotein gp85 gene by a recombinant baculovirus.
    Pulford D; Lowrey P; Morgan AJ
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3241-8. PubMed ID: 7525863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells.
    Whang Y; Silberklang M; Morgan A; Munshi S; Lenny AB; Ellis RW; Kieff E
    J Virol; 1987 Jun; 61(6):1796-807. PubMed ID: 3033311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a 70-kDa, EBV gp350/220-binding protein on HSB-2 T cells.
    Hedrick JA; Lao Z; Lipps SG; Wang Y; Todd SC; Lambris JD; Tsoukas CD
    J Immunol; 1994 Nov; 153(10):4418-26. PubMed ID: 7963519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.